Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
Alibaba Health Information Tec (241 HK)
Watchlist
Contact IR
410
Analysis
Consumer Staples
•
China
Alibaba Health Information Technology Limited is an integrated healthcare information and content service provider. The Company uses product identification, authentication, and tracking system data for its healthcare information.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
15 Jun 2025 02:10
HK Short Interest Weekly: Ping An, Catl, Cspc Pharma, Xpeng, Lenovo, Li Auto, Jd Health
We analyzed the latest HK SFC report for aggregate short position as of Jun 6th and highlight short interest changes in Ping An, Catl, Cspc Pharma,...
Ke Yan, CFA, FRM
Follow
152 Views
Share
bullish
•
Alibaba Health Information Tec
•
17 Feb 2025 01:55
Baba's Babies: They're All Grown Up!: Alibaba Health (241 HK) Temperature's Rising!
Ali Health Info Tech price has surged on the back of Alibaba's recent AI announcements including its deal with Apple, the launch of 6 new DeepSeek...
David Mudd
Follow
954 Views
Share
bullish
•
Alibaba Group Holding
•
14 Dec 2022 01:38
China ADRs Delisting - Friday Could Be Judgment Day for over US$800bn Mcap of Stocks
PCAOB officials concluded their Hong Kong visit last month and PCAOB is due to announce its annual judgment on whether it had adequate access to US...
Sumeet Singh
Follow
1.1k Views
Share
bullish
•
Cross Asset Strategy
•
02 Jan 2025 01:30
HONG KONG ALPHA PORTFOLIO (December 2024)
Hong Kong Alpha porfolio returned 5.29% in December and has outperformed Hong Kong indexes by 10% to 14% since its inception on 10/01/24.The...
David Mudd
Follow
955 Views
Share
bullish
•
Shanghai Electric Group Company
•
04 Nov 2024 04:06
HONG KONG ALPHA PORTFOLIO - Introduction
We have launched a Hong Kong portfolio with the aim to outperform HK indexes and generate alpha. Stocks are chosen from those highlighted in our...
David Mudd
Follow
905 Views
Share
1
2
3
4
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x